Korean J Dermatol.
2000 Jan;38(1):38-44.
The Immunohistochemical Study of bcl-2 and p53 Expression of Pilomatricoma
- Affiliations
-
- 1Department of Dermatology, College of Medicine, Hallym University Seoul, Korea.
Abstract
-
BACKGROUND: The pathogenesis of pilomatricoma is unknown. Several reports have suggested that apoptosis
may play a role in the pathogenesis of pilomatricoma. As the bcl-2 and p53 are well-known regulators of apoptosis,
a disturbance in either bcl-2 or p53 could compromise a proper apoptotic response and relate to the development
of the tumor.
OBJECTIVE
The purpose of this study was to evaluate the expression of bcl-2 and p53 proteins in
pilomatricoma.
METHODS
Paraffin blocks of 14 cases of pilomatricoma were stained immunohistochemically by
using anti-bcl-2 and anti-p53 antibodies.
RESULTS
1. Histologically, SCs were found in all 14 pilomatricomas, while BCs and TCs were found each
in 9 tumors.
2. All the SCs found in 14 tumors and all the TCs found in 9 tumors were unstained for both
bcl-2 and p53.
3. The expression of bcl-2 in 9 tumors was variable. Basal BCs showed reactivity from
negativity(-) to strong positivity(+++) and suprabasal BCs showed reativity from negativity(-) to
moderately strong(++) positivity. Both basal BCs and suprabasal BCs showed negativity for bcl-2 in
3 tumors and similar positive staining in 1 tumor, while basal BCs showed stonger positivity than
suprabasal BCs in 5 tumors.
4. The expression of p53 in 9 tumors was also variable. Both basal BCs and suprabasal BCs
showed reactivity from negativity(-) to moderately strong positivity(++). Both basal BCs and
suprabasal BCs showed negativity for p53 in 1 tumor and similar positive staining in 6 tumors,
while suprabasal BCs showed stronger positivity than basal BCs in 2 tumors.
CONCLUSION
The above immunohistochemical findings showed that the expression of bcl-2 and p53
was variable and suggest that both bcl-2 and p53 have a limited role in the control of apoptosis
in pilomatricoma.